In the wake of the study led by ECHA in December 2016, the results show that low oral toxicity in sub-acute tests may not require additional acute oral tests. Indeed, the study suggests that low acute oral toxicity can be predicted from the results of low toxicity in oral sub-acute toxicity studies.
The agency estimates that about 550 chemical registrants will be able to omit in vivo acute oral studies.
Furthermore, the Agency has recommended that registrants� use results from a 28-day oral toxicity study as part of a weight-of-evidence approach in their acute toxicity approach.
Registrant that would like to use the sub-acute toxicity results in their dossier will need to report the following findings: - Results from a 28-day oral toxicity study - Cytotoxicity tests - Qsar - Physico-chemical information about the product.
On the eve of the 2018 registration deadline, ECHA estimates that about one third of the 5,200 substances that have to be registered will need information for the acute oral toxicity endpoint.
For more information, do not hesitate to check out both ECHA �s website and our registration pages or to contact us at contact@ecomundo.eu. You can also call us at +33 (0)1 83 64 20 54 for Europe or +1 (778) 234 1607 for North America. Our experts are happy to help!
In the wake of the study led by ECHA in December 2016, the results show that low oral toxicity in sub-acute tests may not require additional acute oral tests. Indeed, the study suggests that low acute oral toxicity can be predicted from the results of low toxicity in oral sub-acute toxicity studies.
The agency estimates that about 550 chemical registrants will be able to omit in vivo acute oral studies.
Furthermore, the Agency has recommended that registrants� use results from a 28-day oral toxicity study as part of a weight-of-evidence approach in their acute toxicity approach.
Registrant that would like to use the sub-acute toxicity results in their dossier will need to report the following findings: - Results from a 28-day oral toxicity study - Cytotoxicity tests - Qsar - Physico-chemical information about the product.
On the eve of the 2018 registration deadline, ECHA estimates that about one third of the 5,200 substances that have to be registered will need information for the acute oral toxicity endpoint.
For more information, do not hesitate to check out both ECHA �s website and our registration pages or to contact us at contact@ecomundo.eu. You can also call us at +33 (0)1 83 64 20 54 for Europe or +1 (778) 234 1607 for North America. Our experts are happy to help!